Clinical trials
Completed Phase 2 Lymphoproliferative Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 2 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2018 | 2 |
| 2021 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen Research (Munich) GmbH | 4 |
| Mayo Clinic | 2 |
| National Cancer Institute (NCI) | 2 |
| Baylor College of Medicine | 1 |
| Children's Oncology Group | 1 |
| City of Hope Medical Center | 1 |
| Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | 1 |
| Jonsson Comprehensive Cancer Center | 1 |
| Juno Therapeutics, a Subsidiary of Celgene | 1 |
| Masonic Cancer Center, University of Minnesota | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoproliferative Disorders | 21 |
| Lymphoma, Non-Hodgkin | 10 |
| Lymphoma | 9 |
| Lymphatic Diseases | 8 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 8 |
| Lymphoma, Large B-Cell, Diffuse | 7 |
| Immunoproliferative Disorders | 6 |
| Leukemia | 6 |
| Burkitt Lymphoma | 4 |
| Hodgkin Disease | 4 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.